In this episode of Thinking Thoracic, host Dr. Erin Gillaspie talks with Dr. Robert Lentz and Dr. Fabien Maldonado about the groundbreaking VERITAS trial, which is reshaping how clinicians diagnose lung cancer. Published in the New England Journal of Medicine, the VERITAS trial compared navigational bronchoscopy with CT-guided biopsy in a rigorous, randomized design, bringing much-needed evidence to interventional pulmonology. The discussion explores how the study was conceived, why robust device trials are vital to patient outcomes, and what the findings mean for the future of minimally invasive lung diagnostics.

The latest episode of Thinking Thoracic takes on a topic that’s on everyone’s minds: finances. Host Erin Gillaspie, MD, sits down with Lawrence Greiten, MD, and Josh Daily, MD, both from Arkansas Children’s Hospital, to discuss their recent paper examining financial decision-making in cardiothoracic surgery. From training pathways to compensation survey data, the conversation highlights how earnings and financial trade-offs shape career choices and negotiations. Tune in today.

This latest episode of Thinking Thoracic, an STS podcast, features host Erin Gillaspie, MD, in conversation with Jonathan Spicer, MD, a leading thoracic oncologist and clinical trial investigator. The two dive into the landmark CheckMate 816 trial, which helped usher in a new era for immunotherapy in lung cancer treatment. Dr. Spicer shares insights on trial design, clinical outcomes, and what these findings mean for the future of thoracic surgery and oncology. Listen today.

Don’t miss the latest Thinking Thoracic episode as host Erin Gillaspie, MD, is joined by Stephanie Worrell, MD, associate professor, University of Arizona, and thoracic surgeon, Banner Health, for a lively and insightful post-ASCO discussion. Together, they unpack the significance of the CheckMate 577 and Matterhorn trials, and explore what these groundbreaking studies mean for the future of esophageal and gastroesophageal junction cancer care.

In this episode of Thinking Thoracic, Dr. Elliott Servais, Lahey Hospital & Medical Center, joins host Dr. Erin Gillaspie to share how he developed a robotic 1st rib resection program. Recognizing an unmet need at his institution, he seized the opportunity to build a dedicated program. The result? A growing referral network and a newfound enthusiasm for a procedure he once dreaded. 

In this episode of Thinking Thoracic, hear from Christopher Seder, MD, professor of surgery and chief of the thoracic surgery division at Rush University, and Robert Habib, vice president of research and analytics at STS, about the development of the Society’s short-term risk calculators for pulmonary resection and esophagectomy, powered by the General Thoracic Surgery Database with more than 800,000 patient records. They discuss how these models reflect modern surgical practices and incorporate newer, evidence-backed variables, setting a new standard in personalized risk assessment for general thoracic surgery. And they discuss the launch of the widely anticipated STS risk calculator mobile app. Listen today.

What were the most practice-changing thoracic surgery papers of 2024? In this episode of Thinking Thoracic, Dr. Linda Martin, UVA Health, and Dr. Jeff Yang, Thinking Thoracic co-host, spotlight top studies shaping the field, from groundbreaking lung cancer and esophageal cancer findings to surgical profession papers that impact how surgeons work and lead. Dr. Martin’s curated list is a go-to resource for surgeons looking to stay at the forefront of evidence-based care. Check out her GTSC Key Papers presentation here. 

In this episode of Thinking Thoracic, hear from Alexandra Potter, researcher, and Dr. Chi-Fu Jeffrey Yang, both from Massachusetts General Hospital, about a new study that reveals current lung cancer screening guidelines miss nearly half of patients who develop the disease. Alternative approaches could greatly expand access—especially for women, minorities, and former smokers.

Thinking Thoracic host Dr. Erin Gillaspie and Dr. Stephen Liu, associate professor of medicine at Georgetown University and head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, discuss the surgeon's role in navigating the biomarker space and working collaboratively with oncology colleagues.  

In this episode of Thinking Thoracic, co-host Dr. Jeff Yang welcomes Dr. Gavitt Woodard and Dr. Christopher Seder to discuss their recent research on lobectomy versus sublobar resection for early-stage non-small cell lung cancer. Their studies, leveraging data from The STS General Thoracic Surgery Database, provide valuable insights into the long-term survival outcomes of these surgical approaches.

Hear from Dr. Woodard on how her study, recognized as the Richard E. Clark Memorial Paper, aimed to evaluate patient populations that were not well represented in prior randomized trials, such as older adults and those with poorer pulmonary function. Dr. Seder explains how his research took a complementary approach, examining over 32,000 patients from 2012 to 2022, with a focus on distinguishing the survival outcomes between lobectomy, segmentectomy, and wedge resection. Listen today.